跳至主要内容
临床试验/NCT00938483
NCT00938483已完成不适用

A Multicenter, Single-blind, Randomized, Phase II Study of the Tolerability and Safety of NPS-202 in Infants With Clinically Diagnosed Cow's Milk Allergy

Perrigo Nutritionals0 个研究点目标入组 108 人开始时间: 2007年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
108
主要终点
Infant reactivity to an extensively hydrolyzed infant formula

研究概览

简要总结

The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Care Provider)

入排标准

年龄范围
1 Day 至 12 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • clinically diagnosed CMA
  • </= 12 weeks at time of study entry
  • full-term infant
  • must be willing to use provided formula as sole source of nutrition
  • other than CMA, infant must be otherwise healthy

排除标准

  • underlying or confounding gastrointestinal abnormalities
  • infants born from an addictive situation, HIV positive
  • if parent/guardian is considered likely to be non-compliant with the protocol requirements

结局指标

主要结局

Infant reactivity to an extensively hydrolyzed infant formula

时间窗: 29 days

次要结局

未报告次要终点

研究者

申办方类型
Industry

相似试验